A proof of concept for structure-based vaccine design targeting RSV in humans

Crank, Michelle C., Ruckwardt, Tracy J., Chen, Man, Morabito, Kaitlyn M., Phung, Emily, Costner, Pamela J., Holman, LaSonji A., Hickman, Somia P. +43 more·2019·Science
DOI 10.1126/science.aav9033

Cited by (333)

Items 301–333 of 333

  1. A Poorest-First Approach to RSV Vaccine Development
    Natalie I Mazur · 2022
  2. Applications of genetic engineering in COVID-19
    Ysrafil Ysrafil, Sari Eka Pratiwi, Emmanuel Cornillot · 2023 · Elsevier eBooks
  3. Vaccines
    Katherine V. Houser, Myra Happe, Rachel Bean, Emily E. Coates · 2023 · Elsevier eBooks
  4. An Insight into the Active sites of the RNA Polymerase and Proofreading Exonuclease of the Human Respiratory Syncytial Virus
    Peramachi Palanivelu · 2023 · World Journal of Advanced Research and Reviews
  5. We are all on the same team
    Annefleur C. Langedijk · 2023
  6. Clinical validation of an RSV neutralization assay and testing of cross-sectional sera pre- and post- RSV outbreaks from 2021-2023
    Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger · 2024 · medRxiv
  7. 12 Vaccine Candidates for Novel Pathogens
    Karin Bok · 2024 · Springer eBooks
  8. Research progress on the structure of Epstein-Barr virus
    Ling ZHONG, YuFei WANG, Chengyu Yang, Yang Huang, Huiping He, Qingbing Zheng, Xiao ZHANG · 2024 · Scientia Sinica Vitae
  9. Respiratory Syncytial Virus and Human Metapneumovirus
    Gregory J. Berry, N. Esther Babady · 2023 · ClinMicroNow
  10. Respiratory Syncytial Virus and Human Metapneumovirus
    Gregory J. Berry, N. Esther Babady · 2023 · ClinMicroNow
  11. Respiratory syncytial virus G glycoprotein promotes Streptococcus pneumoniae-induced severe pneumonia
    Li Lü, Xin Long, Yushun Wan, Yuncheng Wang, Pixu Shi, Enmei Liu, Yu Deng · 2025 · Research Square
  12. Structure-Guided Vaccine Design
    Nawsad Alam, Matthew K. Higgins · 2025 · Elsevier eBooks
  13. Current status of developments in the field of respiratory syncytial virus vaccines
    Tatiana S. Kotomina · 2025 · Journal of microbiology epidemiology immunobiology
  14. Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
    Hyon‐Xhi Tan, MZM Zheng, Kathleen M. Wragg, Lydia Murdiyarso, Devaki Pilapitiya, A Kelly, Robyn Esterbauer, Christopher A. Gonelli, Adam K. Wheatley, Jennifer A. Juno · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Respiratory syncytial virus vaccines for toddlers and school-aged children: a pressing necessity for global health
    Jie Sheng, Keyu Tao, Chao Zhang, Aiping Zhang, Li Yang, Jianjian Ji · 2025 · Frontiers in Pediatrics
  16. High-stability, clamp-free soluble Sarbecovirus spike trimers and their potential for pan-Sarbecovirus vaccine development
    Christine Langer, Irene Boo, Tasnim Zakir, Charley Mackenzie-Kludas, Johnson Samuel, Stewart A. Fabb, CheeLeng Lee, Anupriya Aggarwal, Stuart Grant Turville, Colin William Pouton et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Real-world data and clinical management experience in passive immunization for respiratory syncytial virus prevention in children
    Yongping Xie, Xin Cong, Yan Li, Lisu Huang · 2025 · Vaccine X
  18. De novo design of a safe and potent respiratory syncytial virus immuno-focusing antigen
    Woo Yeon Hwang, Jinung Song, Jiwon Choe, Keun Bon Ku, Hyung-Sun Kim, Gun Young Yoon, Do Yeon Kim, Mi‐Ra Choi, Eun‐Ji Kim, Jae Seung Lee et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Quantifying the association between neutralising antibodies and protection from RSV disease in infants and adults: A systematic review and meta-analysis
    Alexandra B. Hogan, Ainslie Mitchell, Eva Stadler, Yuna Chung, Arnold Reynaldi, Karen M Elias, Steffen S. Docken, David S. Khoury, Timothy E. Schlub, Miles P. Davenport et al. · 2026 · medRxiv
  20. Structure-guided computational design of high-affinity antibodies enables chemiluminescence immunoassay for C-reactive protein
    Yijian Li, Tonggong Liu, Jingzhe Wang, Xiaona Zhao, Jie Wen, Zhongyan Li, Fuxing Zeng, 顾大勇 · 2026 · Bioorganic Chemistry
  21. A Rabies Virus Glycoprotein Subunit Vaccine Produced in Pichia pastoris Induces Neutralizing Antibodies in Mice
    Ye Yang, Ruo Mo, Zhuoran Hou, Han Wang, Peng Gang Sun, Ruixi Liu, Tiantian Wang, Bin Zhang, Xuchen Hou, Yongkun Zhao et al. · 2026 · Vaccines
  22. Engineering strategies and decision frameworks for virus-like particle-based vaccines against infectious diseases
    Yiyan Liu, Yanan Zhang, Lijuan Liang, Han Zhang, Tianjiao Zhang, Xifeng Rong, Jiying Tan, Youjun Mi · 2026 · Frontiers in Microbiology
  23. Decreased Persistence of Maternal Antibodies in Infants Who Are HIV Exposed and Uninfected
    Yiwei Jiang, Tessa Goetghebuer, Stefan Embacher, Anaïs Thiriard, Véronique Olislagers, Dansala Welba, Martin Taton, Inès Vu Duc, Katty Renard, Shilpee Sharma et al. · 2026 · The Journal of Infectious Diseases
  24. Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines
    Shuai Shao, Ze Yuan Dong, Zi Yao Kang, Hao Zhang, Xiang Zheng, Fu Jie Shen, Yu Qin Jin, Zheng Pan, Xin Li, Ning Liu et al. · 2026 · Biochemical and Biophysical Research Communications
  25. When structural rationales fall short: revisiting the immunogenicity of herpesvirus prefusion and postfusion glycoprotein B
    Julia Nentwig, Kay Grünewald, Benjamin Vollmer · 2026 · Current Opinion in Virology
  26. mRNA vaccines against viral pathogens: molecular design, delivery systems, and clinical applications
    Wei Xu, Jun Wang, Xueke Liu, Mei Lü, Z K Zhang, Li Li · 2026 · Frontiers in Microbiology
  27. A six-proline stabilized trimeric spike DNA vaccine induces robust immunity and protects against SARS-CoV-2 delta challenge in K18-hACE2 transgenic mice
    Aytül Gül, Ceren Gül, Tuğba Karakavuk, Muhammet Karakavuk, Hüseyin Can, Hivda Ülbeği-Polat, Müge Serhatlı, Hilal Yazıcı, Şenay KÖM, Arzu Taş Ekiz et al. · 2026 · Biomedicine & Pharmacotherapy
  28. Malaria serology for surveillance, insights into immunity, and vaccine development
    P. Lim, J. Bernal, Janani Karunarathne, R. Longley · 2026 · Infection and Immunity
  29. What Makes a Good Vaccine Antigen Target? Defining Key Features and Predicting Candidates in the Staphylococcus aureus Proteome
    Nadia K. Prasetyo, Ries J. Langley, Fiona Jane Radcliff, Paul P. Gardner · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Protein language model aided library generation for discovery of affinity peptides targeting the respiratory syncytial virus F protein
    Qiuyang Gong, Qinghong Shi · 2026 · Biochemical Engineering Journal
  31. Intramuscular self-amplifying RNA and adenoviral RSV vaccines program distinct systemic and respiratory mucosal immune architectures
    Yao Zhang, Yu Qin, Zhongbing Qi, Qingzhe Yang, Xian Zhang, Shichuan Hu, Yuejun Li, Boduan Xiao, Jianchuan Hu, Ping Cheng · 2026 · EMBO Molecular Medicine
  32. From Concept to Clinical Trial: Starting Clinical Trials with a New Vaccine
    Stephen P. Lockhart, Michele Sausser, William C. Gruber · 2026 · Springer eBooks
  33. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
    Kayvon Modjarrad, Kena A. Swanson · 2026 · Springer eBooks